series-c-plus
Stage
2014
Founded
1
Investors
About
PulseCath develops percutaneous ventricular assist devices for high-risk percutaneous coronary interventions (PCIs). Its iVAC 2L System pumps blood from the left ventricle to the aorta to maintain patient’s haemodynamic stability during complex medical procedures.
Explore PulseCath's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.